The tumor suppressor PTEN is a negative regulator of mTOR, and it is known that BC patients with germline mutations in PTEN are at increased risk of developing a second breast tumor, as well as endometrial, thyroid, renal, and colorectal cancers [191]. This evidence concerns the gene PTEN and breast neoplasm.